Topics › Drug Policy
Commentary by Gregory Ferenstein and Geoffrey Lawrence
Commentary by Gregory Ferenstein
Commentary by Madison Carlino
Commentary by Christina Dent
Testimony by Geoffrey Lawrence
Commentary by Jacob James Rich
Policy Brief by Michelle Minton and Geoffrey Lawrence
Psychedelics Policy Newsletter by Gregory Ferenstein